Email Alert | RSS    帮助

中国防痨杂志 ›› 2012, Vol. 34 ›› Issue (11): 704-707.

• 论著 • 上一篇    下一篇

2009—2010年北京市登记复治肺结核患者的耐药状况研究

罗萍 张天豪 高志东 邢青 赵瑶 易俊莉 王甦民   

  1. 100035 北京,北京结核病控制研究所门诊部(罗萍、赵瑶),防控科(张天豪、高志东),中心实验室(王甦民、邢青、易俊莉)
  • 收稿日期:2012-06-13 出版日期:2012-11-10 发布日期:2013-02-06
  • 通信作者: 王甦民 E-mail:suminwang085@126.com
  • 基金资助:

    北京市首都发展基金联合攻关课题项目(2007-1020)

The study of drug resistance of retreatment tuberculosis patients in Beijing 2009—2010

LUO Ping, ZHANG Tian-hao, GAO  Zhi-dong, XING Qing, ZHAO Yao, YI Jun-li, WANG Su-min   

  1. Department of Outpatient, Beijing Research Institute of Tuberculosis Control, Beijing 100035 China
  • Received:2012-06-13 Online:2012-11-10 Published:2013-02-06
  • Contact: WANG Su-min E-mail:suminwang085@126.com

摘要: 目的  了解北京地区复治肺结核患者的耐药状况,为结核病防治对策的制定提供依据。  方法  收集2009—2010年北京市复治肺结核患者276例,对分离出的同时有一、二线药物敏感度试验结果的结核分枝杆菌菌株195株进行抗结核药品耐药情况检测并进行分析。耐药率之间的差异性比较采用χ2检验,显著性水平设定为α=0.05。 结果  195株结核分枝杆菌菌株对一线抗结核药品的耐药率为56.4%(110/195),对二线抗结核药品的耐药率为63.6%(124/195),耐多药率28.2%(55/195),广泛耐药率3.1%(6/195);在检测的9种抗结核药品中,耐药率顺位前5位依次为丙硫异烟胺57.9%(113/195)、异烟肼42.6%(83/195)、乙胺丁醇36.4%(71/195)、链霉素34.9%(68/195)和利福平33.8%(66/195);耐药率在性别[男性78.8%(119/151),女性79.5%(35/44)]、年龄分布[“15~岁”82.9%(34/41),“30~岁”83.8%(57/68),“45~岁”79.2%(38/48),“60~岁以上”65.8%(25/38)]、地区[北京市79.2%(103/130)、外地78.5%(51/65)]和登记分类[复发77.7%(122/157),初治失败84.6%(11/13),其他复治84.0%(21/25)]等方面比较,差异均无统计学意义(χ2值分别为0.011、5.328、0.015、0.824;P值均>0.05)。 结论  北京地区复治肺结核患者耐药状况比较严重,应加强对现有治疗管理方法的研究。

关键词: 结核, 肺, 分枝杆菌, 结核, 抗药性, 细菌, 北京市

Abstract: Objective  To understand the drug resistance of retreatment tuberculosis patients in Beijing, and to provide evidence for Beijing TB control.  Methods  One hundred and ninty-five retreatment tuberculosis patients registered in TB control organizations from 2009 to 2010 that had performed both the 1st-line and 2nd-line drug susceptibility tests were collected and analyzed. Chi-square test was used for comparing difference of drug resistant rate,  α=0.05.     Results  The resistance rate of 1st-line anti-TB drugs was 56.4%(110/195), for 2nd-line anti-TB drug resistance rate was 63.6%(124/195), multi-drug resistant(MDR) rate was 28.2%(55/195),extensively-drug resistant(XDR) rate was 3.1%(6/195). Drug resistance rate in the top 5 of the 9 drugs tested were Pto 57.9%(113/195), INH 42.6%(83/195), EMB 36.4%(71/195), S 34.9%(68/195) and RFP 33.8%(66/195).There were no significant difference of drug resistance in different gender[male 788%(119/151),female 79.5% (35/44),χ2=0.011, P>0.05], age group[“15~years old” 82.9%(34/41), “30~years old” 83.8%(57/68), “45~years old” 79.2%(38/48), “60~years old”  65.8%(25/38),χ2=5.328, P>0.05], region[local census register,79.2%(103/130),Nonlocal census register 78.5% (51/65),χ2=0.015, P>0.05]and patient classification [relapse 77.7%(122/157), initial treatment failure 84.6%(11/13),other retreatment 840%(21/25), χ2=0.824, P>0.05].  Conclusion  The drug resistance of retreatment tuberculosis is serious in Beijing. We should strengthen the research on existing treatment methods in TB control in order to meet the evolving needs of capital tuberculosis control under the new situation.

Key words: Tuberculosis, pulmonary, Mycobacterium tuberculosis, Drug resistance, bacterial, Beijing city